Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report.
Brain Stimul. 2024 Mar-Apr;17(2):448-459. doi: 10.1016/j.brs.2024.03.016. Epub 2024 Apr 2.
Brain Stimul. 2024.
PMID: 38574853
Free article.
Clinical Trial.
A prospective, multi-center randomized, controlled, blinded trial of vagus nerve stimulation for difficult to treat depression: A novel design for a novel treatment.
Conway CR, Olin B, Aaronson ST, Sackeim HA, Bunker M, Kriedt C, Greco T, Broglio K, Vestrucci M, Rush AJ.
Conway CR, et al.
Contemp Clin Trials. 2020 Aug;95:106066. doi: 10.1016/j.cct.2020.106066. Epub 2020 Jun 19.
Contemp Clin Trials. 2020.
PMID: 32569757
Free article.
Clinical Trial.
Item in Clipboard
Zinc is a potential therapeutic for chemoresistant ovarian cancer.
Bastow M, Kriedt CL, Baldassare J, Shah M, Klein C.
Bastow M, et al. Among authors: kriedt cl.
J Exp Ther Oncol. 2011;9(3):175-81.
J Exp Ther Oncol. 2011.
PMID: 22070048
Item in Clipboard
Zinc functions as a cytotoxic agent for prostate cancer cells independent of culture and growth conditions.
Kriedt CL, Baldassare J, Shah M, Klein C.
Kriedt CL, et al.
J Exp Ther Oncol. 2010;8(4):287-95.
J Exp Ther Oncol. 2010.
PMID: 21222361
Item in Clipboard
Direct intra-tumoral injection of zinc-acetate halts tumor growth in a xenograft model of prostate cancer.
Shah MR, Kriedt CL, Lents NH, Hoyer MK, Jamaluddin N, Klein C, Baldassare J.
Shah MR, et al. Among authors: kriedt cl.
J Exp Clin Cancer Res. 2009 Jun 17;28(1):84. doi: 10.1186/1756-9966-28-84.
J Exp Clin Cancer Res. 2009.
PMID: 19534805
Free PMC article.
Item in Clipboard
Neuropeptide Y acts at Y1 receptors in the rostral ventral medulla to inhibit neuropathic pain.
Taylor BK, Abhyankar SS, Vo NT, Kriedt CL, Churi SB, Urban JH.
Taylor BK, et al. Among authors: kriedt cl.
Pain. 2007 Sep;131(1-2):83-95. doi: 10.1016/j.pain.2006.12.018. Epub 2007 Feb 2.
Pain. 2007.
PMID: 17276005
Free PMC article.
Item in Clipboard
Cite
Cite